VAERS reports by lot

Pfizer COVID-19 lot HG4629: VAERS reports

72 VAERS reports list lot HG4629 as a Pfizer COVID-19 vaccine, received between 2023-09-23 and 2024-10-02. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
72
Reports
4%
Marked serious
1
With a death outcome
11
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction3919%
General / Systemic (non-local)3718%
Neurological2914%
Musculoskeletal2612%
Gastrointestinal2512%
Cardiac / Cardiovascular178%
Allergic / Anaphylactic168%
Dermatological (non-injection-site)94%
Respiratory84%
Psychiatric / Neuropsychiatric21%
Thrombotic / Hematological10%

Where reports came from

U.S. state of the reporter, where given (top 12).

California17
New Jersey5
Texas5
Florida4
New York4
Michigan4
Arizona3
Massachusetts3
Rhode Island2
Pennsylvania2
Minnesota2
Maryland1

Reports by month received

2023-097
2023-1020
2023-116
2023-123
2024-0110
2024-027
2024-033
2024-041
2024-052
2024-0612
2024-101

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.